This inventor holds 2 USPTO granted patents. Top assignees: Bgi Shenzhen, Mgi Tech Co., Ltd.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 56 
2 out of 59 Years Active: 2021-2025
Title: Lingling Peng: Innovator in Nucleoside Analogues
Introduction
Lingling Peng is a notable inventor based in San Jose, California, recognized for his contributions to the field of nucleoside analogues. With a total of two patents to his name, he has made significant strides in the development of innovative methods for sequencing nucleic acids.
Latest Patents
Lingling Peng's latest patents include "Reversibly Blocked Nucleoside Analogues and Their Use." This invention provides methods for using such nucleoside analogues in the sequencing of nucleic acids. The advancements in this area have the potential to enhance the efficiency and accuracy of genetic sequencing.
Career Highlights
Throughout his career, Lingling has worked with prominent companies such as MGI Tech Co., Ltd. and BGI Shenzhen. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the field of biotechnology.
Collaborations
Lingling has collaborated with notable professionals, including Handong Li and Snezana Drmanac, who have also made significant contributions to the field. Their combined efforts have fostered innovation and advancement in nucleic acid research.
Conclusion
Lingling Peng's work in the development of reversibly blocked nucleoside analogues showcases his commitment to advancing biotechnology. His patents and collaborations reflect a dedication to improving genetic sequencing methods, marking him as a key figure in this innovative field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile